Education
About Us
Working with TipRanks
Follow Us
Surgical Science Sweden AB (SE:SUS)
:SUS
SUS Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr106.40 - kr192.40
Previous CloseN/A
Volume39.18K
Average Volume (3M)72.14K
Market Cap
kr7.85B
Enterprise Valuekr2.32B
Total Cash (Recent Filing)kr612.89M
Total Debt (Recent Filing)kr1.64M
Price to Earnings (P/E)55.7
Beta0.92
Next Earnings
Aug 21, 2025EPS Estimate
0.72Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.70
Shares Outstanding51,026,237
10 Day Avg. Volume70,431
30 Day Avg. Volume72,139
Financial Highlights & Ratios
PEG Ratio0.54
Price to Book (P/B)1.97
Price to Sales (P/S)0.00
P/FCF Ratio88.13
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr180.00Price Target Upside19.44% Upside
Rating ConsensusHold
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
7.70%
Mutual Funds
― Other Institutional Investors
91.30% Public Companies and
Individual Investors
SUS FAQ
What was Surgical Science Sweden AB’s price range in the past 12 months?
Surgical Science Sweden AB lowest stock price was kr106.40 and its highest was kr192.40 in the past 12 months.
What is Surgical Science Sweden AB’s market cap?
Surgical Science Sweden AB’s market cap is kr7.85B.
When is Surgical Science Sweden AB’s upcoming earnings report date?
Surgical Science Sweden AB’s upcoming earnings report date is Aug 21, 2025 which is in 44 days.
How were Surgical Science Sweden AB’s earnings last quarter?
Surgical Science Sweden AB released its earnings results on May 14, 2025. The company reported kr0.705 earnings per share for the quarter, beating the consensus estimate of kr0.439 by kr0.266.
Is Surgical Science Sweden AB overvalued?
According to Wall Street analysts Surgical Science Sweden AB’s price is currently Undervalued.
Does Surgical Science Sweden AB pay dividends?
Surgical Science Sweden AB does not currently pay dividends.
What is Surgical Science Sweden AB’s EPS estimate?
Surgical Science Sweden AB’s EPS estimate is 0.72.
How many shares outstanding does Surgical Science Sweden AB have?
Surgical Science Sweden AB has 51,026,237 shares outstanding.
What happened to Surgical Science Sweden AB’s price movement after its last earnings report?
Surgical Science Sweden AB reported an EPS of kr0.705 in its last earnings report, beating expectations of kr0.439. Following the earnings report the stock price went up 5.385%.
Which hedge fund is a major shareholder of Surgical Science Sweden AB?
Currently, no hedge funds are holding shares in SE:SUS
Company Description
Surgical Science Sweden AB
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; simbionix simulators; and robotic surgery simulators. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden.
Technical Analysis
CellaVision AB
―
Paxman AB
―
Senzime AB
―
C-Rad AB Class B
―
Vicore Pharma Holding AB
―